Amlitelimab Marketing Summer 2026 Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Sanofi · 23 hours ago

Amlitelimab Marketing Summer 2026 Intern

Sanofi is an innovative global healthcare company committed to transforming the lives of people with immune challenges and rare diseases. They are seeking a Summer Intern to support the Amlitelimab team in developing a US Brand Plan and conducting competitive analysis.

Health CareLife SciencePharmaceuticalTherapeutics
badNo H1Bnote

Responsibilities

Assist the US Amlitelimab team in the development of a US Brand Plan leveraging the Amlitelimab Global Brand Plan as a foundation
Key sections of the brand plan that the Summer Intern may work on include:
Situation Analysis
SWOT
Strategic Imperatives & Critical Success Factors

Qualification

Stakeholder managementStrategic thinkingProject managementCompetitive analysisCross functional teamwork

Required

Currently enrolled and pursuing a bachelor's or master's degree in biology or related life-sciences at an accredited college or university with the expectation that you will complete your current degree by the Spring of 2028
Must be able to relocate to the office location and work 40hrs/week, Monday-Friday, for the full duration of the co-op/internship
Must be enrolled in school the semester following your internship/co-op with Sanofi
Must be permanently authorized to work in the U.S. and not require sponsorship of an employment visa (e.g., H-1B or green card) at the time of application or in the future

Benefits

Enjoy a thoughtful, well-crafted rewards package that recognizes your contribution and amplifies your impact.
Exposure to cutting-edge technologies and research methodologies.
Networking opportunities within Sanofi and the broader biotech community.

Company

Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.

Funding

Current Stage
Public Company
Total Funding
$6.97B
Key Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B

Leadership Team

leader-logo
Paul Hudson
Chief Executive Officer
linkedin
leader-logo
Francois-Xavier Roger
Chief Financial Officer
linkedin
Company data provided by crunchbase